Evidence map›Paper›PMID 30935025›Full record

ArticleToxins2019

First Characterization of The Venom from

Jacinthe Frangieh, Yahya Salma, Katia Haddad, Cesar Mattei, Christian Legros, Ziad Fajloun, Dany El Obeid

Abstract read
In one paragraph

Article in Toxins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Article
  7. Iranian journal of veterinary research · 2025
    Article
  8. Article
  9. Influence ofToxins · 2025
    Article
  10. Effect ofMolecules (Basel, Switzerland) · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Antimicrobial Activity ofAntibiotics (Basel, Switzerland) · 2023
    Article
  18. Review
  19. Pharmacological properties and therapeutic potential of honey bee venom.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  20. Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jacinthe FrangiehLaboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and its Applications, EDST, Lebanese University, Tripoli 1300, Lebanon. jacynthefrangieh@gmail.com.
Yahya SalmaLaboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and its Applications, EDST, Lebanese University, Tripoli 1300, Lebanon. yahyasalma@ul.edu.lb.
Katia HaddadFaculty of Sciences 3, Lebanese University, Michel Slayman Tripoli Campus, Ras Maska 1352, Lebanon. khaddad@ul.edu.lb.
Cesar MatteiMitochondrial and Cardiovascular Pathophysiology ⁻ MITOVASC, Team 2, Cardiovascular Mechanotransduction, UMR CNRS 6015, INSERM U1083, Angers University, 49045 Angers, France. cesar.mattei@univ-angers.fr.ORCID 0000-0002-2214-2611
Christian LegrosMitochondrial and Cardiovascular Pathophysiology ⁻ MITOVASC, Team 2, Cardiovascular Mechanotransduction, UMR CNRS 6015, INSERM U1083, Angers University, 49045 Angers, France. christian.legros@univ-angers.fr.
Ziad FajlounLaboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and its Applications, EDST, Lebanese University, Tripoli 1300, Lebanon. ziad.fajloun@ul.edu.lb.
Dany El ObeidFaculty of Agriculture & Veterinary Sciences, Lebanese University, Dekwaneh, Beirut 2832, Lebanon. delobeid@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bee venom is a mixture of several components with proven therapeutic benefits, among which are anti-inflammatory, analgesic, and various cardiovascular conditions. In this work, we analyzed for the first time the proteomic content and biological properties of the crude venom from

Indexed as

Bee Venoms3T3 CellsAnimalsAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsBacteriaBeesBiphenyl CompoundsCell SurvivalErythrocytesHemolysisHumansMCF-7 CellsMiceMiddle East1,1-diphenyl-2-picrylhydrazylAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsBee VenomsBiphenyl CompoundsPhospholipases A2PicratesApis mellifera syriacabee venomin vitro effectsLC-ESI-MSmelittinsolid phase extraction

Identifiers

PMID30935025
PMCPMC6521255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.